Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

To streamline early discovery, a cross-disciplinary, data-driven workflow process is key

Posted on February 23rd, 2018 by in Pharma R&D

“Complex” is the term that best describes the conditions that affect us. Whether it’s a disease or a consequence of a natural process such as aging, there are no simple fixes. Continue reading “To streamline early discovery, a cross-disciplinary, data-driven workflow process is key” »

Introducing the Hive’s newest class of innovative start-ups

Posted on February 14th, 2018 by in The Hive

In 2017, Elsevier introduced a new program called The Hive, an innovation initiative for biotech and pharmaceutical start-ups committed to promoting collaboration and inspiration across the Pharma & Life Sciences industry.

Continue reading “Introducing the Hive’s newest class of innovative start-ups” »

Harnessing big data — it’s challenging, but it can be done

Posted on February 12th, 2018 by in Pharma R&D

Rubius logo

Today’s big data has the power to drive innovation in ways that the pharmaceutical industry could previously only dream of. Yet harnessing that power comes with an equally sizable challenge: it will require an enormous shift in how research is performed. Continue reading “Harnessing big data — it’s challenging, but it can be done” »

In pharmacovigilance, effective search strings are key

Posted on February 9th, 2018 by in Pharmacovigilance

A key component of any pharmacovigilance strategy is building search strings that successfully identify potential adverse events, which must be reported to regulatory agencies. If the query returns too narrow a result set, adverse events may be missed. Continue reading “In pharmacovigilance, effective search strings are key” »

  1. 1
  2. 2